2 February 2026 (Monday) - Learning Monday
29 January 2026 (Thursday) - IBMS Newsletter
The IBMS sent their
newsletter today. You can see it by clicking
here. In the past I’ve been less than complimentary about it… and I am
again today. Again there’s absolutely nothing of interest to me in it. And I’ll
make the observation that back in the day (before the Internet) people
only joined the IBMS because their magazine was *the* place where jobs
in this line of work were advertised.
There’s only one job advert in this month’s newsletter (I counted)…
28 January 2026 (Wednesday) - Levetiracetam
I saw an interesting case today. Clearly an iron-deficiency anaemia. They are quite common. But this one was in someone who was on Levetiracetam. It’s an anticonvulsant which whilst supposedly not causing iron deficiency, it is recommended that people on that medication should take iron supplements. I’ve updated my atlas to include this case, and here’s some expert opinion on the matter
27 January 2026 (Tuesday) - BTLP-TACT Exercise
26 January 2026 (Monday) - Transfusion Evidence Alert Update
The nice people at the Transfusion
Evidence Alert sent their update today. Again there was talk of frozen
platelets. It would seem they aren’t as good as fresh ones, but fresh ones are
only good for five days; frozen ones keep for two years…
ARTICLE OF THE MONTH
Cryopreserved vs liquid-stored platelets for the treatment of surgical bleeding: the CLIP-II randomized noninferiority clinical trial.
Reade, M.C., et al. (2025). JAMA. [Record in progress].
PICO SUMMARY
TOP ARTICLES
Engasertib versus placebo for bleeding in hereditary hemorrhagic telangiectasia.
Al-Samkari, H., et al. (2025). The New England Journal of Medicine.
Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birthweight infants.
Andersen, C., et al. (2025). The Cochrane Database of Systematic Reviews.
Red cell physiologic stress results in lower quality transfusions: a randomized trial in adults with sickle cell disease.
Karafin, M.S., et al. (2025). Blood Red Cells Iron.
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study.
Kattamis, A., et al. (2025). Orphanet Journal of Rare Diseases.
The efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis of randomized controlled trials.
Lai, Y., et al. (2025). Frontiers in Pharmacology.
Effect of multidisciplinary team-based refined nursing on outcomes in elderly patients with liver cirrhosis and upper gastrointestinal bleeding.
Li, S., et al. (2025). Journal of Visualized Experiments: JoVE.
A standard blood bank donation improves cardiometabolic health of donors: a double-blind randomised controlled trial.
Mora-Gonzalez, D., et al. (2025). British Journal of Haematology. [Record in progress].
Risk assessment tools for predicting transfusion in surgery: a systematic review and meta-analysis.
Seyahian, A., et al. (2025). Health Technology Assessment. [Record in progress].
Liberal versus restrictive red blood cell transfusion thresholds in acute acquired brain injury: a systematic review and meta-analysis.
Sud, S., et al. (2025). BMJ Open.




